H. Yoshida

Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore.

T. Seki, T. Fujiwara, T. Yoshinaga, 2012, Journal of medicinal chemistry.

Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles.

E. Garvey, T. Seki, T. Fujiwara, 2013, Journal of medicinal chemistry.

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).

E. Garvey, T. Seki, S. Foster, 2013, Journal of medicinal chemistry.

Practical and Scalable Synthetic Method for Preparation of Dolutegravir Sodium: Improvement of a Synthetic Route for Large-Scale Synthesis

Y. Aoyama, M. Nagai, T. Yasukata, 2019, Organic Process Research & Development.